SCOT-HEART 2

In the SCOT-HEART 2 trial, we will recruit at least 6,000 people from Scotland who are at risk of heart disease and will compare two ways of deciding how to prevent future heart problems. We will compare the current standard of care, using a Scottish ‘risk score’, with a CTCA scan to look at the heart.  This will help us find out if making decisions based on the results of a CTCA will stop too many people being given medicines they don’t really need, and see whether it lowers the number of people developing heart disease.

Chief Investigator: Prof David Newby

Number and location of participating sites / geographical scope (by region/ country): Western General Hospital Edinburgh (Recruitment), Royal Infirmary Edinburgh (Scanning)

Image

Funder: British Heart Foundation

Start and End date

Of grant award: 01/04/2019 - 01/04/2027  

Of recruitment: 13 January 2020

Current Status: Open

Trial website - The SCOT-HEART 2 Trial

Sponsor: ACCORD http://www.accord.ed.ac.uk/

Chief Investigator: Professor David Newby, Centre of Cardiovascular Science, Chancellor's Building, 49 Little France Crescent, Edinburgh, EH16 4SB

E-mail: d.e.newby@ed.ac.uk

Trial Manager: Gill Scott, Edinburgh Clinical Trials Unit,  Usher Institute, University of Edinburgh, Edinburgh BioQuarter, 5-7 Little France Road, Edinburgh EH16 4UX

Email: SCOT.HEART2@ed.ac.uk

UK GDPR Privacy Statement: Information can be found in our Participant Information Sheets.

You can find out more about how we use your information

• By asking one of the research team

• By sending an email to SCOT.HEART2@ed.ac.uk

• By contacting a Data Protection Officer

ECTU Involvement: Trial management / Data base / Data Management / Admin support / Health Economics

(UKCRC)